NEW YORK, Oct 27, 2017 /PRNewswire/ — A retrospective analysis, reported in the journal Breast Cancer Research and Treatment, of more than 8,189 women with invasive breast cancer and 1,158 women diagnosed with metastatic breast cancer (MBC) between 1990 and 2010 identified differences in tumor characteristics and survival due to breast cancer in women diagnosed with de
Metastatic breast cancer makes you “presumptively eligible” for disability benefits from the Social Security Administration (SSA) through their Compassionate Allowances Program, but it is not a guarantee. You still need to apply and meet the SSA’s technical qualification rules which include strict financial limits for Supplemental Security Income (SSI) and/or work credit requirements for Social Security Disability Insurance
In January 2016, the Metastatic Breast Cancer Alliance (the Alliance) convened a think tank of stakeholders from academia, government, industry, and patient advocacy to discuss gaps and opportunities in clinical and translational research in metastatic breast cancer.
The American Society of Clinical Oncology (ASCO) is hosting more than 35,000 cancer researchers, doctors, patient advocates and industry representatives from around the world in Chicago for their 55th annual meeting. Much anticipated new data is being presented relevant to breast cancer, and particularly, metastatic breast cancer.
More than 150,000, new study shows. The number of women living with MBC is increasing. The lack of robust epidemiological statistics on the number of people living with metastatic breast cancer (MBC) was highlighted as one of many critical gaps to making advances for MBC in our Landscape Report.